Sapio Sciences launches Partner program to accelerate research and diagnostics

Baltimore, MD — Sapio Sciences, the science-awareTM lab informatics platform, announces the

Cellular Origins appoints Geoffrey Hodge as Non-Executive Director

Appointment brings additional significant strategic, technical and commercial experience to the Board

Closed Loop Medicine selected to join NVIDIA Inception

London, UK: Closed Loop Medicine Ltd., a leading TechBio company developing combination prescription drug-plus-software precision therapy products that deliver personalized dose optimization to treat the individual, not just the disease, has joined the NVIDIA Inception program.

Newcells Biotech appoints Emile Shaffu as Director of Sales

Key commercial appointment follows a series of executive team changes to support ongoing company expansion

H.E.L Group appoints Professor Yih-Shing Duh as Chief Scientific Advisor

Expert in battery testing further strengthens H.E.L’s expertise in thermal safety Professor Duh will be delivering two seminars on behalf of H.E.L Group on 11-12th July at Xiamen University, demonstrating application of H.E.L’s BTC adiab

Cellular Origins acquires ACTIA Platform IP to enhance automated cell therapy manufacturing

Autologous Cell Therapy Industrial Automation (ACTIA) strengthens technology and IP portfolio of Cellular Origins supporting ongoing development and expanding capabilities of Constellation platform

Bio-Rad launches ChemiDoc Go Imaging System

Compact system uses CMOS Digital Imaging and is compatible with chemiluminescence and fluorescence detection and stain-free technology

HERCULES, Calif.

Bio-Rad launches Celselect Slides 2.0 to advance rare cell and circulating tumor cell enrichment for cancer research

New Celselect Slides™ Design Increases Efficiency of Circulating Tumor Cell Capture from Liquid Biopsy Samples for Enumeration and Downstream Applications

Hercules Calif. — Bio-Rad Laboratories, Inc.

Sapio Sciences introduces Sapio GMP LIMS offering unmatched flexibility for unique manufacturing processes

Sapio Sciences announces key new capabilities to its highly flexible, no/low-code LIMS to support laboratories that must comply with GMP, 21 CFR 11, and EU Annex 11 standards

Baltimore, MD: Sapio Sciences

Bio-Rad extends range of anti-biotherapeutic antibodies to accelerate antibody drug development

Four New Anti-Idiotypic Antibodies and a New Anti-MMAE Antibody Range Support Bioanalytical Assay Development for Preclinical Research and Clinical Trials

Hercules, Calif - Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products

Bio-Rad launches ddSEQ™ Single-Cell 3' RNA-Seq Kit for Single-Cell Gene Expression

ddSEQ™ Single-Cell 3' RNA-Seq Kit and Omnition v1.1 Analysis Software Enable High-Quality and Affordable Single-Cell Transcription and Gene Expression to Support Molecular Biology, Oncology, and Drug Discovery Research.

Gyros Protein Technologies introduces Gyrolab Generic Anti-AAV Kit to support gene therapy development

Ready-to-use kit enables detection of binding antibodies against AAV vectors without the need for serotype-specific assays

Enterprise Therapeutics appoints Dr Renu Gupta as Chief Medical Officer and Dr Janet Hammond as Non-Executive Director

Brighton, UK: Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering from respiratory disease, announces the appointment of Dr Renu Gupta as CMO (Chief Medical

Enterprise Therapeutics publishes preclinical profile of ETD001, a novel inhaled ENaC blocker

Low doses of ETD001 demonstrate exceptionally long duration of action in sheep model of airway mucus clearance Report in Journal of Cystic Fibrosis discloses best-in-class profile of ETD001 ETD001 scheduled to commence Phase 2 clinical study in p

Newcells Biotech strengthens executive and US team with key appointments

Dr Valeria Chichagova appointed as Director of Technology, Dr Colin Brown as Chief Scientific Officer, and Professor Lyle Armstrong as Scientific Advisor New US commercial appointments also announced to meet growing global demand for products and services

MediMab Biotherapeutics opens bespoke laboratory facilities, created by Kadans Science Partner, at Abingdon Science Park, UK

New CL2 wet lab purpose-built facilities delivered by Kadans Science Partner will support MediMab Biotherapeutics to identify first-in-class immuno-oncology drugs that can actively target a range of advanced and solid tumours Kadans has also completed on Barton Hous

VALANX Biotech announces promising results in first in-vivo study of novel protein conjugate therapy

Study demonstrates pre-clinical efficacy of lead program VLX101 in treating autoimmune disease

DefiniGEN and Atelerix collaborate to ship in vitro cell models internationally without the need for freezing or cryopreservation

Cambridge and Newcastle UK: DefiniGEN Ltd., and Atelerix Ltd., announces they have successfully shipped in vitro liver models from the UK to a top tier pharma customer in the US.

H.E.L Group extends sales and support with appointment of specialist distributors

Distributors will provide added application specific support for H.E.L’s biotechnology and chemical synthesis product portfolios in the USA, Spain and Portugal.

Cellular Origins and Cell and Gene Therapy Catapult collaborate to demonstrate universal automation of CGT manufacturing

Partnership to develop and implement Cellular Origins’ robotic platform Constellation for universal automation of CGT manufacturing at CGT Catapult’s Stevenage Manufacturing Innovation Centre

Secarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics

Partnership expands spectrum of Secarna’s capabilities for the development of targeted ASOs beyond antibodies and sugar molecules

Exonate appoints Dr Rafiq Hasan as Non-Executive Director

Appointment brings extensive experience in global pharma leadership and progressing ophthalmology drugs to market and further strengthens Board

Closed Loop Medicine appoints Paul Johnson as Non-Executive Director

Appointment of digital healthcare leader to Board to support the Company as it enters next phase of commercial development Co-founder and former CEO of Lemonaid Health, a leading innovator in telemedicine and prescription drug delivery, acquired by 23andMe in 2021

ERS Genomics and IRBM sign CRISPR/Cas9 license agreement

License agreement provides IRBM access to CRISPR gene editing technology to be applied across its drug discovery services offering

Closed Loop Medicine and Pharmanovia commence OptiZest study for their first precision medicine combination therapeutic

Proof-of-Concept study to investigate personalized dose management of first-line anti-hypertensive in improving blood pressure control remotely Key milestone in co-development partnership to combine leading medicine brands with dose optimization technology